| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Highlights That the Company Has Delivered Negative Returns and Underperformed Other Healthcare Facility Operators Over All Relevant Periods – Causing it to Trade at a Deep Discount to its Intrinsic Value
Believes Acadia's Underperformance Stems from Poor Execution, a Flawed Reorganization Under CEO Christopher Hunter, Ballooning Costs, Poor Capital Allocation, and a Lack of Board Oversight
Urges the Company to Immediately Halt Growth Capital Projects, Prioritize Operational and Cost Structure Improvements, Explore Potential Asset Sales, and Repurchase Undervalued Shares
Makes Clear the Board Needs to Be Refreshed with New Directors Who Bring Behavioral Health Operating Experience and Capital Allocation Expertise
Engine Capital LP (together with its affiliates, "Engine" or "we"), which owns approximately 3% of the outstanding shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) ("Acadia" or the "Company"), today sent a letter to the Company's Board of Directors outlining opportunities to close Acadia's significant valuation gap and unlock value for shareholders.
Posted In: ACHC
